NCT06679465View on ClinicalTrials.gov

Evaluating the Impact of Single Dose Tiotropium on Allergen-induced Early Asthmatic Response

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

January 1, 2025

Primary Completion Date

January 31, 2027

Study Completion Date

January 31, 2027

Conditions
Asthma Bronchiale
Interventions
DRUG

Tiotropium (Spiriva®)

2 puffs tiotropium prior to allergen challenge

DRUG

Placebo

2 puffs placebo

Trial Locations (1)

S7M 2W2

University of Saskatchewan, Saskatoon

All Listed Sponsors
lead

University of Saskatchewan

OTHER